Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
glargine
Description:
A long-acting insulin analog used as a basal medication to control blood glucose in people with diabetes.
Primary topic:
Diabetes Treatment and Management (36%)
Related topics:
Diabetes Treatment and Management (36%),
Diabetes Management and Research (30%)
Wikidata ID:
wiki/Q417317
OpenAlex ID:
keywords/glargine
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
2011
·
Guillermo E. Umpierrez
, Dawn Smiley
, et al.
·
Diabetes Care
·
776
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)
2007
·
Guillermo E. Umpierrez
, Dawn Smiley
, et al.
·
Diabetes Care
·
717
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
2009
·
L. G. Hemkens
, U. Grouven
, et al.
·
Diabetologia
·
642
PDF
Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78‐week randomized, double‐blind, placebo‐controlled trial
2015
·
J. Rosenstock
, A. Jelaska
, et al.
·
Diabetes Obesity and Metabolism
·
272
PDF
Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes
2013
·
Guillermo E. Umpierrez
, Dawn Smiley
, et al.
·
Diabetes Care
·
245
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
2008
·
Matteo Monami
, Niccolò Marchionni
, et al.
·
Diabetes Research and Clinical Practice
·
233
Long‐acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta‐analysis
2008
·
M. Monami
, N. Marchionni
, et al.
·
Diabetes Obesity and Metabolism
·
219
Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation
2010
·
N Waugh
, E Cummins
, et al.
·
Health Technology Assessment
·
202
Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment.
2004
·
Isaac F Federiuk
, Heather M Casey
, et al.
·
PubMed
·
200
Adjust to Target in Type 2 Diabetes
2008
·
Richard M. Bergenstal
, Mary Johnson
, et al.
·
Diabetes Care
·
198
Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activities in cultured cancer cells
2009
·
Doron Weinstein
, Meital Simon
, et al.
·
Diabetes/Metabolism Research and Reviews
·
193
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
2013
·
Guillermo E. Umpierrez
, Roma Gianchandani
, et al.
·
Diabetes Care
·
186
Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
2023
·
Rachel Sinha
, Dimitris Papamargaritis
, et al.
·
Journal of Obesity & Metabolic Syndrome
·
181
PDF
Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial
2016
·
Francisco J Pasquel
, Roma Gianchandani
, et al.
·
The Lancet Diabetes & Endocrinology
·
174
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
2022
·
The GRADE Study Research Group
·
New England Journal of Medicine
·
173
PDF
Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells
2004
·
Simona I. Chisalita
, Hans J. Arnqvist
·
American Journal of Physiology-Endocrinology and Metabolism
·
151
Simplification of Insulin Regimen in Older Adults and Risk of Hypoglycemia
2016
·
Medha N. Munshi
, Christine Slyne
, et al.
·
JAMA Internal Medicine
·
141
PDF
Hospital Discharge Algorithm Based on Admission HbA1c for the Management of Patients With Type 2 Diabetes
2014
·
Guillermo E. Umpierrez
, David Reyes
, et al.
·
Diabetes Care
·
141
Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function.
2004
·
Jennifer A Mayfield
, Russell D White
·
PubMed
·
136
Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections
2008
·
A. Nicolucci
, A. Maione
, et al.
·
Diabetic Medicine
·
135
DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results
2009
·
John B. Buse
, Bruce H.R. Wolffenbuttel
, et al.
·
Diabetes Care
·
134
Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
2015
·
Virginia Bellido
, Lorena Suarez
, et al.
·
Diabetes Care
·
129
PDF
Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies
2013
·
Oystein Karlstad
, Jacob Linde
, et al.
·
Current Drug Safety
·
128
PDF
Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability
2006
·
John C. Pickup
, Julia Kidd
, et al.
·
Diabetes/Metabolism Research and Reviews
·
128
Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis
2014
·
A. C. Tricco
, H. M. Ashoor
, et al.
·
BMJ
·
125
PDF
Show more works
View as search
Works count:
931
Citation count:
15,380
Year
Topic
Type